Elbit Medical Technologies Ltd
ELBDF
$0.05
-$0.01-16.67%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | 135.50K | 271.00K | 271.00K | 271.00K |
| Total Revenue | -- | 135.50K | 271.00K | 271.00K | 271.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 135.50K | 271.00K | 271.00K | 271.00K |
| SG&A Expenses | 495.00K | 515.00K | 535.00K | 538.50K | 542.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 495.00K | 515.00K | 535.00K | 538.50K | 542.00K |
| Operating Income | -495.00K | -379.50K | -264.00K | -267.50K | -271.00K |
| Income Before Tax | 827.00K | -7.00M | -14.83M | -16.31M | -17.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.83 | -7.00 | -14.83 | -16.31 | -17.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 827.00K | -7.00M | -14.83M | -16.31M | -17.79M |
| EBIT | -495.00K | -379.50K | -264.00K | -267.50K | -271.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.15 | -0.23 | -0.31 | -0.25 | -0.19 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.15 | -0.23 | -0.31 | -0.25 | -0.19 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 181.43M | 187.81M | 194.20M | 278.53M | 362.86M |
| Average Diluted Shares Outstanding | 375.63M | 382.01M | 388.39M | 375.63M | 362.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |